Recent studies indicate that cGAS-STING pathway activation can promote PD-L1 expression on cancer cells, potentially providing a means for these cells to elude the anti-tumor response (Kwon and Bakhoum, 2020; Lu et al., 2023). The gene discussed is STING1; the disease is neoplasm.